PCSK9 and cancer: Additional therapeutic strategies aiming at PCSK9 inhibition, such as ASOs, adnectin, anticalin, pseurotin A (PS), and various natural products, have been delineated and show profound potential for inhibiting PCSK9 function across cellular and animal cancer models.